MedPath
TGA Approval

FLUBLOK trivalent recombinant influenza vaccine, Influenza haemagglutinin recombinant 135 mcg, 0.5 mL solution for injection syringe (446791)

446791

FLUBLOK trivalent recombinant influenza vaccine, Influenza haemagglutinin recombinant 135 mcg, 0.5 mL solution for injection syringe

Sanofi-Aventis Australia Pty Ltd

May 9, 2025

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/40f98ae2be78173d07ad907ae7e94a0a.pdf

Active Ingredients

Influenza haemagglutinin recombinant

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FLUBLOK trivalent recombinant influenza vaccine, Influenza haemagglutinin recombinant 135 mcg, 0.5 mL solution for injection syringe (446791) - TGA 批准文号 | MedPath